Stay Clear of ZM Stock Until It Gives Back a Lot More Ground

On Sept. 1, Zoom Video (NASDAQ:ZM) stock was executing a “dead cat bounce.” As in, even a dead cat will bounce if thrown from high enough up. After reporting “disappointing” results, net income of $317 million, $1.04 per share, on revenue of $1.02 billion, up 54% year over year, the stock tanked. ZM dropped nearly …

NVDA Stock Is Finally Showing Signs of Fatigue After Its Big Rally

Nvidia (NASDAQ:NVDA) stoc has pulled back from the all-time highs after a red-hot run post-earnings. NVDA stock traded just past the $230 level before ultimately losing momentum. Certainly, some of the rally was warranted given the earnings beat and dovish Fed speak from Jackson Hole. The relentless rally has now come too far, too fast. …

HOOD Stock Continues To Disappoint as It Risks Becoming Generic

Since before Robinhood (NASDAQ:HOOD) stock went public a month ago, the phrase “Robinhood stock” has been part of the vocabulary. These are stocks beloved of small investors, who often trade on Robinhood’s app and exchange views on Reddit’s r/Wallstreetbets. But after looking at its June quarter earnings report and what has happened since, the ultimate …

NVAX Stock Is a Steal Here If You Believe It Will Come Through

Novavax (NASDAQ:NVAX) stock could trade in the $100 billion market capitalization range like BioNTech (NASDAQ:BNTX) or Moderna (NASDAQ:MRNA). Except, unlike those companies, Novavax has not yet delivered. It might be among the most-watched firms that did not yet bring a Covid-19 vaccine to market. Chances are low that it will slump like Altimmune (NASDAQ:ALT) after …

BABA Stock Is Ready for a Bounce After Getting Staight with Beijing

Timing a market bottom is a notoriously difficult thing to do. So, I won’t claim that now is the definitive time to invest in Alibaba (NYSE:BABA) stock. However, pundits have to admit that the case for maximizing returns by buying low looks very near.  The truth is that Alibaba was never likely in any jeopardy …

Fraud Allegations Are Unlikely to Keep SAVA Stock Down

Allegations of fraud against Cassava Sciences (NASDAQ:SAVA) are unlikely to stop its Alzheimer’s drug candidate from quickly advancing to a Phase 3 clinical trial. As a result, I remain very bullish on SAVA stock. One of the most important reasons is an issue that hasn’t been explored very much yet. Specifically, none of the allegations …

3 Energy Stocks Popping with Oil: XLE, COP, HES

Oil prices pushed past $70 for the first time in a month in late-day trading Thursday. The rally is breathing new life into the energy sector, which is up 2.5% at this writing. For the past quarter, energy stocks have been lagging the broader market, so shareholders are cheering the newfound strength. To celebrate the …

DKNG Stock: DraftKings Is A Buy Before The Football Season

A leader in the online sports gambling industry, DraftKings (NASDAQ:DKNG) is expanding its presence across the States and is expected to benefit from the upcoming football season. The company is making well-timed moves to build new offerings and achieve growth. It has successfully partnered with some of the top sports companies to offer a unique experience …

Can Speculators Trust the Latest Swing Up in SKLZ Stock?

Although special purpose acquisition companies, or SPACs, gained notoriety over the trailing year-and-a-half period, they do offer a clear advantage to retail investors. Without these blank-check firms, regular folks may not have a chance to buy names like Skillz (NYSE:SKLZ) stock. That’s because traditional market debuts are comparatively onerous, perhaps enough so to prevent SKLZ …

Is BABA Stock a Value-Growth Play or a Value Trap?

I have been wrong on Alibaba (NYSE:BABA) thus far. I kept expecting the “Dogs of the Dow” theory to come into play, where underperforming, high-quality tech stocks would fetch a bid. For BABA stock — and others, like Amazon (NASDAQ:AMZN) until very recently — that hasn’t panned out too well.   Unlike Alibaba though, at …